Coagulant Jar-Test to Purchase Order: Data and Acceptance Criteria
TL;DR A coagulant jar test becomes procurement evidence only when the water matrix, mixing sequence, settling or filtration endpoint, residual targets and acceptance criteria are recorded. Compare PAC, PFS, alum, ferric or polymer candidates under controlled, representative conditions; repeat the best option; then use the result to define a bounded purchase specification. A laboratory dose screens candidates—it is not an automatic plant setpoint.
What should a coagulant jar test record?
A defensible file begins before the jars are filled. EPA guidance notes that there is no single standard jar-test protocol: the procedure needs to represent the treatment objective and be consistent enough to repeat. Capture the raw-water source, sampling time, preservation and baseline measurements; the exact candidate product and relevant COA/TDS/SDS; rapid and slow mixing settings; settling or filtration endpoint; and the numerical acceptance rule agreed by operations and procurement. Re-test the leading condition with representative water before turning it into an order requirement.
| Record field | Why it affects a purchase decision | Evidence to retain | Boundary |
|---|---|---|---|
| Water matrix | pH, alkalinity, temperature, turbidity, colour/NOM, conductivity and relevant metals or suspended solids affect coagulation response. | Sampling point/time, analytical method, units, preservation and source/process changes. | A single grab sample is not a permanent raw-water specification. |
| Mixing and separation sequence | Rapid mix, flocculation energy/time and settling or filtration endpoint determine what the laboratory actually simulated. | Jar volume, equipment, sequence, mixing program, settling/filtration method and timing. | Teaching examples are not universal plant settings; match the local process before scaling. |
| Candidate identity | Procurement needs to know what was compared, not only a trade description. | Candidate code, lot where available, COA, TDS, SDS, delivery form and test dilution. | A category name does not prove a replacement is equivalent. |
| Endpoints and repeatability | Clear success rules prevent an attractive floc from replacing treated-water evidence. | Residual turbidity/colour or agreed analyte, pH, settled/filtered result, replicate runs and observations. | Laboratory endpoints require pilot or plant confirmation where system hydraulics differ. |
Which acceptance criteria convert a jar test into a purchase order?
Write acceptance criteria as a traceable package rather than a single minimum dose. Include the representative-water envelope, candidate documents, test sequence, measured endpoint(s), repeatability expectation, decision owner and the trigger for a plant or pilot confirmation. EPA’s scale-up guidance cautions that jar tests can differ from full-scale contact and hydraulics; that difference belongs in the acceptance plan rather than being hidden by a laboratory result.
| Candidate family | Useful jar-test question | What the purchase file should specify | What the test cannot establish alone |
|---|---|---|---|
| PAC or PFS | Does the selected iron- or aluminium-based coagulant meet the stated endpoint under the representative matrix and mixing sequence? | Declared chemistry/document package, test basis, endpoint and approved-water envelope. | All-season dosage, residual control or equivalence of a different formulation. |
| Alum | How does it compare under the same pH, alkalinity and separation conditions? | Same controlled comparison and site-specific handling/compatibility requirements. | That a classroom or historical condition will reproduce the same result. |
| Ferric coagulant | Does it achieve the agreed treated-water endpoint without unacceptable process side effects in the tested matrix? | Candidate identity, endpoint, residual/handling review and repeat-run evidence. | Universal pH, dose or solids-management outcome. |
| Coagulant aid / polymer | Does order of addition improve the agreed endpoint while preserving a stable, repeatable floc? | Polymer form, preparation method, addition point/order and controlled comparison record. | Final plant feed setting or suitability in a different shear environment. |
Jar-test to purchase-order workflow
- Frame the decision. State whether the objective is turbidity, colour, phosphorus, metals, solids separation or an upstream protection target; select the measurement method before seeing a result.
- Control the comparison. Keep the water batch, mix sequence, jar volume and separation endpoint comparable. Record pH adjustment or polymer addition rather than treating it as background noise.
- Use evidence, not appearance alone. Record settled/filtered-water data, residuals where relevant, floc observations and replicate variability. A photograph of a clear jar is not a procurement specification.
- Document the candidate. Retain COA, TDS, SDS, packaging/delivery form and the exact product identity. Ask what changes require a re-test.
- Release conditionally. Define the water/process envelope, incoming-document checks and site confirmation. Escalate when source water, process loading or separation hardware changes.
Procurement checklist: data, documents and change control
- Raw-water and, where relevant, treated-water analysis with sampling context, pH, temperature, turbidity, alkalinity, colour/NOM and site-specific analytes.
- Jar apparatus, volume, rapid/slow mixing sequence, order of addition, settling or filtration endpoint and all timing.
- Candidate identity, COA, TDS, SDS, delivery concentration/form, batch/lot traceability where supplied and storage/handling needs.
- Measured acceptance endpoint, analytical method, replicates, result variability, test operator and approval owner.
- Plant/pilot confirmation scope, stop criteria, incoming acceptance documents and re-test triggers for water or formulation changes.
Use this purchase-control workflow alongside the coagulants and flocculants category, the practical jar-test procedure guide, the alum, PAC and PFS comparison and the PAC selection guide. For a site-specific review, send the controlled data pack through technical inquiry; this page does not prescribe a field dose or guarantee a plant result.
Frequently asked questions
What should a coagulant jar test record?
Record the representative water matrix and sampling context, candidate identity and documents, dose as a test variable, order of addition, rapid and slow mixing, settling or filtration method, measured endpoints, replicate results and the decision owner. Include the limitations and the conditions that require a re-test.
How do I turn a jar test into a purchase specification?
Define the water/process envelope, candidate documents, controlled test method, numerical acceptance endpoints, repeatability requirement, incoming-document checks and site confirmation gate. Reference the exact tested candidate rather than assuming every product in the same chemical family is equivalent.
Is a laboratory coagulant dose a plant setpoint?
No. A laboratory dose is a candidate-screening result under stated water, mixing and separation conditions. Confirm it against representative process hydraulics, controls and monitoring before assigning a plant operating setting; revise it when water or process conditions change.
Should PAC, alum, ferric and polymer be compared in the same jar test?
They can be compared only with a controlled, documented method and a relevant treatment endpoint. Their chemistry, pH/alkalinity response, residual and handling considerations differ, so the result should identify each candidate and should not collapse them into one generic coagulant claim.
Why repeat the best jar-test condition?
Repeat runs reveal whether the apparent winner is stable within the sampled water and method. Replication improves the procurement record, but it still does not replace pilot or plant confirmation where full-scale mixing, contact time, filtration or source water differs.
About the author and evidence
VCYCLETECH Technical Team prepares application content from current public technical guidance, peer-reviewed or technical sources and product documentation. It does not certify facilities, turn generic images into site evidence, or provide a universal chemical dose, equipment result, compatibility guarantee or legal advice. Final decisions need representative site data, document review and site-specific verification.
References
- US EPA: consistent, site-specific jar-test protocol context
- US EPA: treatment-plant jar-test worksheets and simulation context
- US EPA: treatability testing and laboratory-to-full-scale scale-up boundary
Related: Coagulants & flocculants · Jar-test guide · Polyacrylamide PAM · Technical inquiry